CAREFUSION CORPORATION
Manufacturer adverse-event records for CAREFUSION CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2009–2025 · thin-book · elevated Death-code · balanced
Volume signature
CAREFUSION CORPORATION is a thinner MAUDE footprint
CAREFUSION CORPORATION accounts for 3,843 FDA MAUDE reports (#426 of 434, thin-book tercile). Death-coded event_type share is 1.35% (elevated); Injury share 15.5% (balanced).
What the volume reading shows for CAREFUSION CORPORATION
The standout signal for CAREFUSION CORPORATION is filing volume: 3,843 adverse-event reports in FDA MAUDE (#426 of 434, thin-book). Death-coded event_type share sits at 1.35% (elevated).
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 20 device types, led in this extract by Malfunction at 3,175 (82.6% of event_type total). Peak single-year volume reaches 955 reports across 15 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.